Barely Significant
← all excerpts

Heterogeneous prognosis and adjuvant chemotherapy in pathological stage I non-small cell lung cancer patients.

Thorac Cancer · 2015 · PMC4567008 · PMID 26445611

Europe PMCDOI
1
hedged sentence
0.0530
closest p · 1.1× alpha
0.0530
boldest claim

The sentences

only marginally significantP = 0.053so close (0.05 < p ≤ 0.1)
Although we found that adjuvant chemotherapy tended to increase patient survival in p-stage I NSCLC patients with poorly differentiated tumors, this survival benefit was only marginally significant ( P = 0.053).

also in 5,085 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.